Clinical characteristics, laboratory findings, radiographic signs and outcomes of 61,742 patients with confirmed COVID-19 infection: A systematic review and meta-analysis

Abstract

Introduction In the current time where we face a COVID-19 pandemic, there is no vaccine or effective treatment at this time. Therefore, the prevention of COVID-19 and the rapid diagnosis of infected patients is crucial. Method We searched all relevant literature published up to February 28, 2020. We used Random-effect models to analyze the appropriateness of the pooled results. Result Eighty studies were included in the meta-analysis, including 61,742 patients with confirmed COVID-19 infection. 62.5% (95% CI 54.5–79, p < 0.001) of patients had a history of recent travel endemic area or contact with them. The most common symptoms among COVID-19 infected patients were fever 87% (95% CI 73–93, p < 0.001), and cough 68% (95% CI 55.5–74, p < 0.001)), respectively. The laboratory analysis showed that thrombocytosis was present in 61% (95% CI 41–78, p < 0.001) CRP was elevated in 79% (95% CI 65–91, p < 0.001), and lymphopenia in 57.5% (95% CI 42–79, p < 0.001). The most common radiographic signs were bilateral involvement in 81% (95% CI 62.5–87, p < 0.001), consolidation in 73.5% (95% CI 50.5–91, p < 0.001), and ground-glass opacity 73.5% (95% CI 40–90, p < 0.001) of patients. Case fatality rate (CFR) in <15 years old was 0.6%, in >50 years old was 39.5%, and in all range group was 6%. Conclusions Fever and cough are the most common symptoms of COVID-19 infection in the literature published to date. Thombocytosis, lymphopenia, and increased CRP were common lab findings although most patients included in the overall analysis did not have laboratory values reported. Among Chinese patients with COVID-19, rates of hospitalization, critical condition, and hospitalization were high in this study, but these findings may be biased by reporting only confirmed cases.

MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells

“…Compared with the recent epidemic outbreaks of SARS-CoV-1 and MERS-CoV, which had significantly higher case fatality rates, SARS-CoV-2 causes mild or asymptomatic disease in most cases ( Petrosillo et al., 2020 ; Wang et al., 2020 ; Yu et al., 2020 ; Yuen et al., 2020 ). Eighty percent of cases of severe disease have occurred in patients older than 65 years and those with compromised immune systems ( Chowdhury et al., 2020 ; Pormohammad et al., 2020 ; Zhang et al., 2020a ). Importantly, a study of 50 COVID-19 patients with a range of disease severity found that IFN responses were higher in patients with mild to moderate disease but were lower in severely ill patients ( Hadjadj et al., 2020 ).…”

Managing ICU surge during the COVID-19 crisis: rapid guidelines

“…Therefore, an understanding of number of patients and capacity, resource utilization is essential to adequately address the 'staff, ' 'stuff, ' 'space' and 'systems' to mount a surge response [6,8,16,17]. [40,41] that described outcomes of adult COVID-19 patients in the ICU. The reporting of outcomes, clinical course as well as the definitions varied among studies, and most lacked a full description of the clinical picture and resource use of ICU patients.…”

A Pattern Categorization of CT Findings to Predict Outcome of COVID-19 Pneumonia

“…As of May 29, 2020, 5,704,736 laboratory-confirmed cases and 357,736 deaths have been reported ( 2 ). Numerous studies have revealed the epidemiological, clinical, and radiological characteristics of the novel coronavirus disease (COVID-19) ( 3 – 6 ). Despite the fact that more than 80% of infected patients manifest with only mild clinical symptoms ( 3 ), early identifying the risks of an adverse outcome remains the key to optimize management and improve survival.…”